231 related articles for article (PubMed ID: 10087815)
1. [The new debate on cholesterol: is the lowest level the best?].
Olsson AG
Lakartidningen; 1999 Feb; 96(6):648-52. PubMed ID: 10087815
[No Abstract] [Full Text] [Related]
2. [Primary and secondary prevention of coronary disease by statins].
Ferrières J
Ann Cardiol Angeiol (Paris); 1999 Feb; 48(2):128-36. PubMed ID: 12555337
[TBL] [Abstract][Full Text] [Related]
3. Recent developments in coronary heart disease prevention: the Scandinavian and west of Scotland studies.
Elam MB; Cushman W; Applegate WB; Heimberg M
Tenn Med; 1997 May; 90(5):189-92. PubMed ID: 9130876
[No Abstract] [Full Text] [Related]
4. Overlap analysis of the West of Scotland coronary prevention study (WOSCOPS).
Lim PO; Yee KM
Circulation; 1999 Aug; 100(6):686. PubMed ID: 10441109
[No Abstract] [Full Text] [Related]
5. [Can the action of statins reveal etiology of coronary diseases?].
Werkö L
Lakartidningen; 2001 Oct; 98(42):4566-7. PubMed ID: 11715228
[No Abstract] [Full Text] [Related]
6. [Statins in primary prevention of coronary heart disease].
Paulweber B
Wien Med Wochenschr; 1999; 149(5-6):129-38. PubMed ID: 10408004
[TBL] [Abstract][Full Text] [Related]
7. [For coronary disease patients is certain: the lower the LDL the better].
MMW Fortschr Med; 2006 Jun; 148(24):6. PubMed ID: 16850797
[No Abstract] [Full Text] [Related]
8. Updated guidelines support even lower cholesterol levels for at-risk patients.
Levenson D
Rep Med Guidel Outcomes Res; 2004 Aug; 15(15):1, 6-7. PubMed ID: 15320342
[No Abstract] [Full Text] [Related]
9. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
Jones PH; Hunninghake DB; Ferdinand KC; Stein EA; Gold A; Caplan RJ; Blasetto JW;
Clin Ther; 2004 Sep; 26(9):1388-99. PubMed ID: 15531001
[TBL] [Abstract][Full Text] [Related]
10. [Misleading cholesterol statistics].
Ravnskov U
Lakartidningen; 1999 Apr; 96(16):1947, 1949. PubMed ID: 10330861
[No Abstract] [Full Text] [Related]
11. [Statin treatment in type 2 diabetes. Is it a must today?].
Faust M
MMW Fortschr Med; 2003 Feb; 145(9):35-6. PubMed ID: 12666527
[No Abstract] [Full Text] [Related]
12. Treatment of high-risk patients with ezetimibe plus simvastatin co-administration versus simvastatin alone to attain National Cholesterol Education Program Adult Treatment Panel III low-density lipoprotein cholesterol goals.
Feldman T; Koren M; Insull W; McKenney J; Schrott H; Lewin A; Shah S; Sidisin M; Cho M; Kush D; Mitchel Y
Am J Cardiol; 2004 Jun; 93(12):1481-6. PubMed ID: 15194017
[TBL] [Abstract][Full Text] [Related]
13. [Current developments in prevention of coronary heart disease].
Windler E
Z Arztl Fortbild (Jena); 1996 Feb; 90(1):7-10. PubMed ID: 8650967
[TBL] [Abstract][Full Text] [Related]
14. [Coronary disease prevention: only the inhibition of inflammation is important. Why lower lipids, too?].
Sudhop T; von Bergmann K
MMW Fortschr Med; 2003 May; 145(21):19. PubMed ID: 12845862
[No Abstract] [Full Text] [Related]
15. Critical appraisal of revised cholesterol guidelines for the very high-risk patient.
Rosenson R; Lloyd-Jones D;
Expert Rev Cardiovasc Ther; 2005 Jan; 3(1):173-8. PubMed ID: 15739256
[TBL] [Abstract][Full Text] [Related]
16. [Intensive LDL lowering to under 80 mg/dl: hypercholesteremia patients with stable coronary disease and diabetes profit especially significantly].
MMW Fortschr Med; 2005 Aug; 147(33-34):50-1. PubMed ID: 16138640
[No Abstract] [Full Text] [Related]
17. Treating hypercholesterolemia aggressively.
Wilson CS
Nebr Med J; 1996 Jan; 81(1):3-4. PubMed ID: 8584066
[No Abstract] [Full Text] [Related]
18. [Statins plus inhibition of cholesterol absorption. Dual mechanism of action in lipid therapy].
MMW Fortschr Med; 2002 Sep; 144(35-36):51. PubMed ID: 12380358
[No Abstract] [Full Text] [Related]
19. [Simvastatin 40 mg as secondary prophylaxis: Effective, tolerable and cost-efficient!].
Hernborg A; Hjemdahl P; Håkansson J
Lakartidningen; 2006 Mar 15-21; 103(11):858, 861; discussion 861-2. PubMed ID: 16613120
[No Abstract] [Full Text] [Related]
20. Cholesterol lowering. Should it continue to be the last thing we do?
Waters D
Circulation; 1999 Jun; 99(25):3215-7. PubMed ID: 10385491
[No Abstract] [Full Text] [Related]
[Next] [New Search]